• Advertise
  • Contact Us
  • Write For Us
  • Our Team
Extraction Magazine
No Result
View All Result
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
No Result
View All Result
Extraction Magazine
No Result
View All Result
Home Industry News

New Consumer Study Shows CBD (Cannabidiol) is the Next Big Industry Disruptor, for Pharma and Beyond

Shared Content by Shared Content
August 4, 2019
in Industry News
New Consumer Study Shows CBD (Cannabidiol) is the Next Big Industry Disruptor, for Pharma and Beyond

NEW YORK, July 25, 2019 /PRNewswire/ — New research from Grail Insights reveals how CBD is fast becoming a substitute for traditional products used to treat everything from anxiety to joint pain. CBD – the non-psychoactive cannabinoid, rumored to be the cure for nearly everything, is now found in a multitude of products.

A recent survey of 1,069 US consumers shows 85% of people are aware of CBD, and one in five have tried and/or are currently using CBD. And trial shows no signs of stopping. According to the study, over 60% of those who have not yet tried CBD are interested in doing so.

READ ALSO

Live Resin vs Live Sugar vs Live Rosin: What Food and Pharma Quality Systems Teach Extractors

Top 10 Plants Used for Hydrosol Production, and the Quality Lessons Each One Teaches

With CBD sales expected to hit $22 billion worldwide by 2022, the consumer research firm had to ask, what are consumers giving up in favor of CBD? What do industries stand to lose as a result of CBD adoption? And if they are fast and agile enough, what do they stand to gain?

You can find out more in Grail’s Top Ten Reasons Big Pharma and ‘Mood Management’ Brands Should Brace for Impact.

Not surprisingly, Big Pharma is in CBD’s cross-hairs, be it prescription or over-the-counter medications. The Grail study shows nearly one in six Americans diagnosed with either joint pain, migraines or insomnia uses CBD to manage the condition.

Millennials see CBD as an alternative or a supplement to managing common conditions of their generation. Amongst CBD users between the ages of 18-35, 65% use it for managing stress, and 51% use it for depression and/or anxiety.

Big Pharma is not alone. Alcohol, tobacco, beverages, personal care, and pet products are all feeling the impact of the CBD Revolution. Some alcohol users see CBD as a lower-calorie alternative to the relaxation benefits of alcohol. And take note big tobacco: one in three US smokers has already tried CBD, and 1 in 10 are regular users. An additional 56% are interested in trying it.

Want to learn more about these findings? Contact Melissa Bane at melissa.bane@grailinsights.com

About Grail Insights

Grail Insights is a strategic insights consultancy helping clients seize opportunities and respond decisively to market change by applying insights to any aspect of their business.

SOURCE Grail Insights

Related Posts

Botanical Extraction

Live Resin vs Live Sugar vs Live Rosin: What Food and Pharma Quality Systems Teach Extractors

November 16, 2026
Botanical Extraction

Top 10 Plants Used for Hydrosol Production, and the Quality Lessons Each One Teaches

November 15, 2026
Botanical Extraction

What Is Steam Distillation? Lessons From Food, Pharma and Supplements for Extraction Operators

November 15, 2026
Equipment

Fractional Distillation vs Short Path Distillation: What Pharma and Food Plants Can Teach Extraction Operators

November 11, 2026
Botanical Extraction

Hydrosol vs Essential Oil: Which Product Stream Should Your Facility Be Built Around?

November 9, 2026
Business

What Should Investors Check Before Funding a Cannabis Extraction Operation?

November 6, 2026
Next Post
As Bipartisan Support for Cannabis Banking Reform Grows, Congress Should Advance SAFE Banking Act, says NCR

As Bipartisan Support for Cannabis Banking Reform Grows, Congress Should Advance SAFE Banking Act, says NCR

Sitemap

© 2026 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.

No Result
View All Result
  • Industry News
  • Botanical Extraction
  • Medical Research
  • Medical Research
  • Glossary
  • Our Team
  • Write For Us

© 2026 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.